Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany
|
|
|
- Jessie Marsh
- 7 years ago
- Views:
Transcription
1 Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany
2 Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section 2 A few more words on Novartis Section 3 How a company functions Section 4 Career Opportunities for Bio- and Life Scientists Section 5 Career development opportunities Section 6 Key learning
3 in m US$ Total Revenue in m USD Overview on the Top Ten Pharmaceutical companies Total revenue and R&D expenses of the Top Ten Pharmaceutical Companies results Pfizer GSK Sanofi Av. Novartis Astra Zeneca J&J Merck Roche Eli Lilly Wyeth Total revenue R&D expenses 3 Careers in Industry / Career Workshop WH Jan 2010
4 What do they spend for Research & Development? 40% 2008 R&D expenses as % of total revenue Roche 35% 30% 25% 20% Merck Novartis 15% Sanofi Aventis GSK 10% Series1 Vaccine manufacturers Series2 in m US $ Pharma 4 Careers in Industry / Career Workshop WH Jan 2010
5 Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section 2 A few more words on Novartis Section 3 How a company functions Section 4 Career Opportunities for Bio- and Life Scientists Section 5 Career development opportunities Section 6 Key learning
6 Novartis Research & Development A global network of center of competences UK La Jolla Genomics Gastro-intestinal diseases Respiratory diseases Basel Biomedical Research Epigenetics China Viral Cancers USA Cardiovascular diseases Diabetes & other metabolic dis. Infectious diseases Oncology Ophthalmology Corporate Research (non-profit oriented research) Switzerland Neurology Muscle-skeleton diseases Gastro-intestinal diseases Oncology Transplantation Dermatology Siena Vaccines research for neglected infectious diseases Singapur Tropical infectious diseases 6 Careers in Industry / Career Workshop WH Jan 2010
7 Novartis Institute for Biomedical Research (NIBR) Transforming drug discovery World-class research organization with about scientists globally Unique research strategy driven by patient needs Focus on the biological and molecular pathways shared by various diseases Cambridge global NIBR headquarters Integration of clinical insights with mechanistic understanding of disease should result in finding a molecular target structure Research-to-Development transition redefined through fast and rigorous proof-of-concept trials Strategic alliances with academia and biotech 7 Careers in Industry / Career Workshop WH Jan 2010
8 Fortune World s Most Admired Companies Novartis named #2 in pharmaceutical industry #1 Pfizer J&J J&J J&J Novartis J&J J&J #2 BMS Pfizer Novartis Novartis J&J Novartis Novartis #3 J&J Eli Lilly Eli Lilly Abbott Roche Merck Abbott #4 Merck Merck Abbott Amgen Eli Lilly Abbott Merck #5 Eli Lilly Novartis Pfizer GSK GSK Eli Lilly GSK #6 GSK GSK GSK Eli Lilly Amgen GSK Amgen #7 Novartis Abbott Amgen Roche Abbott Roche AstraZ #8 Pharmac. AstraZ Roche AstraZ Wyeth Amgen Eli Lilly #9 Wyeth Roche AstraZ Wyeth SanofiA Wyeth Wyeth #10 Aventis Aventis Wyeth Pfizer AstraZ AstraZ Boehr.Ing Rating Careers in Industry / Career Workshop WH Jan 2010
9 The Scientist Best Places To Work for Postdocs Novartis ranked #7 among top ten international institutions 9 Careers in Industry / Career Workshop WH Jan 2010
10 The Scientist Best Places To Work Novartis ranked #7 among top large companies 10 Careers in Industry / Career Workshop WH Jan 2010
11 Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section 2 A few more words on Novartis Section 3 How a company functions Section 4 Career Opportunities for Bio- and Life Scientists Section 5 Career development opportunities Section 6 Key learning
12 How does a company function? First of all: You must have a good, if not the best product in the market! At least the product must have a competitive advantage. The 3 Basic Strategies to build Competitive Advantages Product Differentiation Service Differentiation Price Differentiation Advantage by Clear Focus Product Technology Leadership Competence Leadership Overall Cost Leadership Process Technology Leadership Many forms of focussing: - Geographic markets - Market segments -Buyer groups -Product lines - etc. Source: Michael E. Porter, Competitive Advantage 12 Careers in Industry / Career Workshop WH Jan 2010
13 Cost Structure Biopharmaceutical Industry Successful Biopharmaceuticals invest up to 50% of their revenues in R&D and S&M To be able to cover this future investments and to achieve a minimum target income of 10% the G&A and COGs expenditures are limited to a maximum of 40%. 100% 50% 20 25% 5 10% G&A 0thers <1% 10 45% COGs 10 20% Target Operating Income I&T Net Income 20 25% R&D S&M I&T = Interests and Taxes COGS = Cost of goods (manufacturing costs) G&A = General and Administrative costs S&M = Sales and Marketing R&D = Research and Development Source: Mercer Management Consulting; GAVI report Careers in Industry / Career Workshop WH Jan 2010
14 3 How a company is structured Strategic Processes Develop Vision & Strategy, e.g. the Strategic Plan Develop objectives, outputs and outcomes, e.g. Business Planning, Annual objectives Develop structure, processes and resource needs, e.g. Project Portfolio Management, Capital Investment Decisions Franchise Life Cycle Management or Disease Area Planning Alliance Management / Business Development Monitor, review and adapt all of the above Development to Launch Research & Preclinical Development Strategic Marketing Project Management Process &Tech Development Clinical Development RA Submission / Dossier Management Business Enabling Pre- Launch (support processes) Demand and Supply Production and Logistic Planning Technical Services (engineering, maintenance, validation) Industrializations / Design and build or upgrade platforms for new products Quality Assurance / Total Quality Management Regulatory Affairs Pharmaco-vigilance Business Intelligence HR Management IT Management Finance & Reporting Legal Procurement General Site Services HSE & BCM Design & build Quality Control / Quality Operations for new products Corporate Communications & Public Affairs Procurement Primary and Secondary Manufacturing QC, Batch review and Release (QA) Demand Management Shipping and Transportati on Selling Operational Marketing Customer Relationship Management Customer Service Tender management Medical / Scientific support Sales Product Communications & Public Affairs 14 Careers in Industry / Career Workshop WH Jan 2010
15 Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section 2 A few more words on Novartis Section 3 How a company functions Section 4 Career Opportunities for Bio- and Life Scientists Section 5 Career development opportunities Section 6 Key learning
16 3 Which functions need Bio- or life scientists? Strategic Processes Develop Vision & Strategy, e.g. the Strategic Plan Develop objectives, outputs and outcomes, e.g. Business Planning, Annual objectives Develop structure, processes and resource needs, e.g. Project Portfolio Management, Capital Investment Decisions Franchise Life Cycle Management or Disease Area Planning Alliance Management / Business Development Monitor, review and adapt all of the above Development to Launch Research & Preclinical Development Strategic Marketing Project Management Process &Tech Development Clinical Development RA Submission / Dossier Management Pre- Launch Demand and Supply Production and Logistic Planning Procurement Primary and Secondary Manufacturin g Technical Services (engineering, maintenance, validation) Industrializations / Design and build or upgrade platforms for new products Design & build Quality Control / Quality Operations for new products QC, Batch review and Release Demand Management Shipping and Transportati on Selling Operational Marketing Customer Relationship Management Customer Service Tender management Medical / Scientific support Sales Product Communications & Public Affairs Business Enabling Quality Assurance / Total Quality Management Regulatory Affairs Pharmaco-vigilance Business Intelligence HR Management IT Management Finance & Reporting Legal Procurement General Site Services HSE & BCM Corporate Communications & Public Affairs (support processes) Direct needs 16 Careers in Industry / Career Workshop WH Jan 2010
17 3 Which functions need Bio- or life scientists? Strategic Processes Develop Vision & Strategy, e.g. the Strategic Plan Develop objectives, outputs and outcomes, e.g. Business Planning, Annual objectives Develop structure, processes and resource needs, e.g. Project Portfolio Management, Capital Investment Decisions Franchise Life Cycle Management or Disease Area Planning Alliance Management / Business Development Monitor, review and adapt all of the above Development to Launch Research & Preclinical Development Strategic Marketing Project Management Process &Tech Development Clinical Development RA Submission / Dossier Management Pre- Launch Demand and Supply Production and Logistic Planning Procurement Primary and Secondary Manufacturin g Technical Services (engineering, maintenance, validation) Industrializations / Design and build or upgrade platforms for new products Design & build Quality Control / Quality Operations for new products QC, Batch review and Release Demand Management Shipping and Transportati on Selling Operational Marketing Customer Relationship Management Customer Service Tender management Medical / Scientific support Sales Product Communications & Public Affairs Business Enabling Quality Assurance / Total Quality Management Regulatory Affairs Pharmaco-vigilance Business Intelligence HR Management IT Management Finance & Reporting Legal Procurement General Site Services HSE & BCM Corporate Communications & Public Affairs (support processes) Direct needs Indirect needs, for people with broader qualification 17 Careers in Industry / Career Workshop WH Jan 2010
18 Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section 2 A few more words on Novartis Section 3 How a company functions Section 4 Career Opportunities for Bio- and Life Scientists Section 5 Career development opportunities Section 6 Key learning
19 Career development opportunities over the years You influence it / However, others will influence it as well CEO / COO level in USD m Vice President Executive Management level Exec. Director Senior Management level Manager Group Manager Senior Manager Director Management level Expert / Specialist level Careers in Industry / Career Workshop WH Jan 2010 years
20 Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section 2 A few more words on Novartis Section 3 How a company functions Section 4 Career Opportunities for Bio- and Life Scientists Section 5 Career development opportunities Section 6 Key learning
21 Key Learning from working globally in a large enterprise There is no linear development of your career Be prepared for Ups and Downs Globalization drives everything Be flexible, look for opportunities to work abroad Always be clear about the price you are willing to pay Each country has its own management style Some are closer to your heart than others Business is getting faster every year Modern technology allows you to work everywhere, every time Find a work life balance Hierarchy levels are flattened Working in or leading a team is becoming more essential Substantial changes every two three years Offering uncertainties and chances 21 Careers in Industry / Career Workshop WH Jan 2010
22 What really counts! Performance Your Profile (education, languages, your special skills, your personality, social competence) Broaden your portfolio and knowledge, especially in management, economics and marketing Leadership Bite & Resilience Team work, communication and presentation skills Networking Strategic thinking in business and in planning and managing your career 22 Careers in Industry / Career Workshop WH Jan 2010
THE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
Regulatory Affairs Graduate & Postgraduate Program. Novartis Pharma AG Novartis Animal Health AG
Regulatory Affairs Graduate Postgraduate Program Novartis Pharma AG Novartis Animal Health AG The Regulatory Affairs (RA) Graduate Program is an opportunity to discover the global functions of Drug Regulatory
Early Phase Clinical Drug Development
Massachusetts College of Pharmacy and Health Sciences, Worcester, MA Post-PharmD Fellowship Program at Novartis Institutes for BioMedical Research, Cambridge, MA Early Phase Clinical Drug Development Introduction
Creating Joint Value. In Biopharma and Many Other Industries, Not Invented Here Is SO Last Century. By Ben Gomes-Casseres
Creating Joint Value In Biopharma and Many Other Industries, Not Invented Here Is SO Last Century By Ben Gomes-Casseres 36 STRATEGIC ALLIANCE MAGAZINE Q3 2014 Look at any of your alliances. How do you
PharmD Postdoctoral Fellowship Program
Novartis Institutes for Biomedical Research and Massachusetts College of Pharmacy and Health Sciences, Worcester/Manchester PharmD Postdoctoral Fellowship Program Introduction Fellowship training in the
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical
1) SCOPE OF THE PROGRAM
CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany
The Cell Therapy Catapult
The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing
B 3. Biology-Biotechnology-Bridge Program. 2-year Post-Baccalaureate Program. at MIT and its Biotech Partners
B 3 Biology-Biotechnology-Bridge Program 2-year Post-Baccalaureate Program at MIT and its Biotech Partners https://biology.mit.edu/about/postbac_program MIT provides minority outreach in STEM fields at
Quo vadis Pharmaceutical Industry? New strategies to overcome the innovation gap
Quo vadis Pharmaceutical Industry? New strategies to overcome the innovation gap Jochen Maas Stuttgart, May 2014 Quo vadis Pharmaceutical Industry? R&D in the pharmaceutical industry - still a valid model?
Welcome to PP PHARMA PLANING This is a short Presentation of our Services
Welcome to PP PHARMA This is a short Presentation of our Services Willkommen bei PP PHARMA Bitte sehen Sie eine kurze Übersicht zu unseren Dienstleistungen International Executive Search and Specialist
Committed to innovation and growth
Committed to innovation and growth Alan Hippe, CFO Roche Group London, September 2012 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by
Biometrics: Clinical Trials and Beyond
Biometrics: Clinical Trials and Beyond Statistics, Programming, and Data Management in Research, Development, and Regulatory Submissions. For all, Not Just Statisticians! Keynote Presentations Sue-Jane
Future roles and opportunities for statisticians in pharmaceutical industry
Future roles and opportunities for statisticians in pharmaceutical industry H. Ulrich Burger 1), Stefan Driessen 2), Chrissie Fletcher 3), Michael Branson 4), Christoph Gerlinger 5) 1) Hoffmann-La Roche
Join our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management
PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management Contact: +91 9886735658, 080 28411665 ext 5103 Email: crtraining@avesthagen.com PG Diploma In Clinical Research,
Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy
Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS
U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade. N8B7-52 December 2010
U.S. Contract Research Outsourcing Market: Trends, Challenges and Competition in the New Decade December 2010 Table of Contents Notes on Methodology 8 Market Introduction and Segmentation Introduction
The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry
Talentmark Consulting Product Driven People Solutions Press Release The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry Cambridge
Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure
Policy Issues in the Economics and Financing of Medical Technology in the Asia-Pacific Region Dr KAI HONG PHUA Joint Professor Yong Loo Lin School of Medicine and Lee Kuan Yew School of Public Policy National
Quality by Design Concept
3rd Jerusalem Conference on Quality and Pharma Sciences 6-7 June, 2012 QbD in Clinical Research - Where Can QbD Impact Clinical Research Practices? Dr. Yafit Stark Vice President, TEVA Pharmaceutical Industries,
Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595
Transparency Market Research Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample Published Date:
Profile of Biomedical Research and Biotechnology Commercialization. San Diego Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization San Diego Metropolitan Statistical Area Overview and History of Biotechnology in San Diego San Diego has a significant concentration of
Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups
Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation
Key Findings. Use this report to... The Autoimmune Market Outlook to 2013
Key Findings The global autoimmune market generated sales of $31.9bn in, an increase of 14.4% over 2006 sales. The market is forecast to grow at a CAGR of 8.1% to reach a total value of $51.0bn in 2013.
Engineering for the new pharma reality
NNE Pharmaplan is an international company specialised in pharma engineering. We help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions. We have
Roopa Ramamoorthi PhD, PMP, Associate Director, Partnering and Scientific Affairs
Roopa Ramamoorthi PhD, PMP, Associate Director, Partnering and Scientific Affairs BIO Ventures for Global Health Sharing Innovation in the Fight Against Neglected Tropical Diseases World Intellectual Property
A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations
A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations Ce3, Inc. and Insight Genetics, Inc. Oncology Forum July 15, 2015 Agenda Introductions Definitions Regulations
Implication of China 2012 NEDL. Presented by: Li Xingwei Yong Hueyling
Implication of China 2012 NEDL to MNC pharma players Presented by: Li Xingwei Yong Hueyling Content Brief introduction of China NEDL policy China hospital system & MNCs Business Focus Influence of 2012
Annual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
How To Design A Clinical Trial
BioBusiness BioEntrepreneurship Life Sciences Entrepreneurship BioClub BioClub BioBusiness Network at USI Clinical Trials Design and Management for Start-Up Companies LUGANO: 5-6 NOVEMBER 2012 SUPPORTED
Masters Learning mode (Форма обучения)
Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)
Job Profile Clinical Research Associate III (CRA)
PART 1 - PROFILE You are an experienced CRA with a strong background in Clinical Research who is passionate about drug development and are seeking a challenging and rewarding career in a quality focussed
To know more about Pharmacovigilance and Clinical Trials Data Management
To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding
Tuas Biomedical Park
Tuas Biomedical Park About Tuas Biomedical Park Tuas Biomedical Park symbolises JTC s commitment in developing a world-class manufacturing hub for the biomedical industry. The park is located in Tuas View,
EVT Execute & EVT Innovate World-class drug discovery
EVT Execute & EVT Innovate World-class drug discovery Evotec AG, First Quarter Report 2015, 12 May 2015 Forward-looking statements Information set forth in this presentation contains forward-looking statements,
Global Monoclonal Antibodies Pipeline Insight 2015
Brochure More information from http://www.researchandmarkets.com/reports/3113388/ Global Monoclonal Antibodies Pipeline Insight 2015 Description: Ever since the Nobel Prize was bestowed on the person who
2009 Foley & Lardner LLP Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative
Attorney Advertising Prior results do not guarantee a similar outcome Models used are not clients but may be representative of clients 321 N. Clark Street, Suite 2800, Chicago, IL 60654 312.832.4500 Life
Big Data An Opportunity or a Distraction? Signal or Noise?
Big Data An Opportunity or a Distraction? Signal or Noise? Maya R. Said, Sc.D. SVP & Global Head, Oncology Policy & Market Access, Novartis 3rd International Systems Biomedicine Symposium Luxembourg, 28
Pennino Corporation TECHNOLOGY TO IMPROVE LIFE
Pennino Corporation TECHNOLOGY TO IMPROVE LIFE Agenda The Opportunity Highlights Corporate Profile NYU Relationship Obesity and Diabetes Graphics and Facts Next Stage of Development Efficacy and Safety
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO. @LSQld
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO @LSQld LEADING DESTINATION FOR CLINICAL RESEARCH INVESTORS IN QLD INCLUDE: LIFE SCIENCES IN QLD ~300 companies in life sciences ~$5B invested by
Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research
Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from
A clinical research organization
A clinical research organization About Us State of art facility. All clinical trials carried out in accordance with ICH GCP guidelines. Quality services within stipulated time period. Team of experienced
Production in an Innovation Economy: The Globalization of Biomanufacturing and Implications for the Geography of Innovation
Production in an Innovation Economy: The Globalization of Biomanufacturing and Implications for the Geography of Innovation Industry Studies Association Pittsburgh, June 1, 2011 Elisabeth Reynolds, Ph.D.
Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com
Building innovative drug discovery alliances. Profitable. Growth Go
Building innovative drug discovery alliances Innovation n & Profitable Growth Go Evotec AG, H1 Presentation, 8 th August 2012 Forward-looking statements Information set forth in this presentation contains
China Medical Equipment Market Analysis and Forecasts to 2015
Brochure More information from http://www.researchandmarkets.com/reports/1080808/ China Medical Equipment Market Analysis and Forecasts to 2015 Description: China Medical Equipment Market Analysis and
Informatics and Knowledge Management at the Novartis Institutes for BioMedical Research (NIBR)
Informatics and Knowledge Management at the Novartis Institutes for BioMedical Research (NIBR) Enable Science in silico & Provide the Right Knowledge to the Right People at the Right Time to enable the
Industry NHS data sharing for collaborative product development
Industry NHS data sharing for collaborative product development Changing strategies in clinical evidence gathering: Are randomised, doubleblinded studies to become extinct? The RCT is not extinct, but
2019 Healthcare That Works for All
2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To
Even we will get to use your product someday. Enough reason for us to deliver.
Even we will get to use your product someday. Enough reason for us to deliver. ClinInvent: Putting our heart and soul behind the research. At ClinInvent, when we talk about clinical research it s not just
THE LINCOLN INSTITUTE OF HEALTH
THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges
Identity Management & Digital Signatures in the BioPharmaceutical Industry John Hendrix; Program Director CTST 2009
Identity Management & Digital Signatures in the BioPharmaceutical Industry John Hendrix; Program Director CTST 2009 2009 SAFE-BioPharma Association Overview Conducting Business in the Electronic World
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a
www.uea.ac.uk/pha WHAT WILL YOU DISCOVER?
www.uea.ac.uk/pha WHAT WILL YOU DISCOVER? PHARMACOLOGY AND DRUG DISCOVERY UNDERGRADUATE COURSES 2016 WELCOME JOIN US ON A UNIQUE COURSE DESIGNED TO PRODUCE THE UK S NEXT LEADERS IN DRUG DISCOVERY. 1 1
How To Improve Project Management
PRTM Global Management Consultants Successful Portfolio and Resource Management Practices for Pharmaceutical & Biopharmaceutical Companies Industry Benchmarking Report For further information, contact:
Federal Ministry of Education and Research
Federal Ministry of Education and Research Announcement Regulations for funding of products for the prevention, diagnosis and treatment of neglected and poverty-related diseases 1 Funding purpose Poor
Rutgers Mini-MBA : BioPharma Innovation
Rutgers Mini-MBA : BioPharma Innovation Ga i n t h e s k i l l s to t r a n s f o r m scientific i n n ovat i o n i n to business success www.cmd.rutgers.edu/innovation Rutgers Mini-MBA : BioPharma Innovation
Organizational Capital, R&D Assets, and Outsourcing
Organizational Capital, R&D Assets, and Outsourcing Wendy Li 2013 Federal Committee on Statistical Methodology Research Conference Bureau of Economic Analysis November 5, 2013 Motivation and Challenge
Excellence in Oncology Clinical Trials
Oncology Clinical Trials We work to find a better way. We work to raise standards and deliver more. We break new ground to make progress possible. Oncology Research ICON is a global provider of outsourced
How Global Data Management (GDM) within J&J Pharma is SAVE'ing its Data. Craig Pusczko & Chris Henderson
How Global Data Management (GDM) within J&J Pharma is SAVE'ing its Data Craig Pusczko & Chris Henderson Abstract See how J&J Pharma organizational alignment drove the evolution of Global Data Management
The Cost of Innovation in the Pharmaceutical Industry A Review
The Cost of Innovation in the Pharmaceutical Industry A Review Prof. Dr. Alexander Schuhmacher, Reutlingen University, March 2014 Conflict of interest: nothing to disclose 1 Executive Summary Despite scientific,
Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor
Sharing Industry Clinical Trial Data: Improving Public Health While Maintaining the Oversight Relationship Between Regulator and Sponsor Steven Snapinn SCT/QSPI/FDA Workshop Innovations in the Science
Biomanufacturing Vision for the Future
Biomanufacturing Vision for the Future Shou-Bai Chao, Ph.D. Senior Vice President Global Manufacturing and Technical Operations MedImmune (a Div of AstraZeneca) NIPTE/FDA Research Conference Future of
EVT Execute & EVT Innovate Leading drug discovery
EVT Execute & EVT Innovate Leading drug discovery Evotec AG, Nine-month 2015 Interim Report, 10 November 2015 Forward-looking statements Information set forth in this presentation contains forward-looking
2015 / 2016 Awards Criteria and Submission Information
9 th Annual ViE Awards 2015 / 2016 Awards Criteria and Submission Information In association with: Dear colleague, The Vaccine Industry Excellence (ViE) Awards have been created to honor and generate recognition
How To Plan An R&D Strategy
Creating an R&D Strategy Gary P. Pisano Working Paper 12-095 April 24, 2012 Copyright 2012 by Gary P. Pisano Working papers are in draft form. This working paper is distributed for purposes of comment
HCL Healthcare: Meeting Reform Challenges
HCL Healthcare: Meeting Reform Challenges Pradep Nair Senior Vice President Healthcare Practice pnair@hcl.com Agenda Healthcare Industry: Drivers of Change HCL Healthcare Overview Healthcare Sub-Verticals
Location for Trials- Global Considerations A Pharma Perspective. Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014
Location for Trials- Global Considerations A Pharma Perspective Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014 Why Choose Australia for Clinical Trials? What is he saying
October 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892
October 17, 2005 Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 Dear Dr. Zerhouni: The undersigned nonprofit medical and scientific societies
Institute for OneWorld Health
Institute for OneWorld Health a nonprofit pharmaceutical company Oxymoron no more: nonprofits can deliver medicines for the poor of the world January 10, 2005 Victoria Hale, PhD CEO, OneWorld Health The
MEDICAL DEVICE & DIAGNOSTICS
to Guide Strategic Medical Device and Introduction Medical device and diagnostic makers face myriad challenges when developing a new product, including working within resource and financial constraints,
Medical Writing Takes Off in India
Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com
TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298
DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES MAY 2014. May 2014 ABA 298 1 Technologies, Products & Services
The National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
Strategic Value Beyond Savings
Strategic Value Beyond Savings Procurement & Supply Chains Role in Delivering Sustainable Business Success Paula Gildert BSc(Hons) FRSA FCIPS MIET CEng VP Head Global Development Strategic Sourcing, Novartis
THE VIRAL HEPATITIS CONGRESS 2015. 10 12 September 2015, Kap Europa, Frankfurt, Germany THE VIRAL HEPATITIS CONGRESS. Scientific Programme
THE VIRAL HEPATITIS CONGRESS THE VIRAL HEPATITIS CONGRESS 2015 10 12 September 2015, Kap Europa, Frankfurt, Germany Scientific Programme PRE-CONGRESS WORKSHOP SPONSOR ACHILLION Achillion is seeking to
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
Focus on Your Future: PhD and MD-PhD Programs and Research Careers
Focus on Your Future: PhD and MD-PhD Programs and Research Careers TWD Program Director s Meeting Chantilly, VA June 4, 2015 Elise Covic, PhD (University of Chicago, Dean of Students MSTP) Sean Crosson,
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
Strategies to Prepare for Meetings with the FDA. Kim Colangelo Associate Director for Regulatory Affairs Office of New Drugs, CDER, FDA
Strategies to Prepare for Meetings with the FDA Kim Colangelo Associate Director for Regulatory Affairs Office of New Drugs, CDER, FDA Topics for Discussion Who Are We? How Do We Interact Internally? Why
Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization San Oakland San Jose Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in San The San Bay area is in many
Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH
Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH VWR enables the advancement of science by providing high-quality chemicals and services, customized to your
Transforming relationships Unleashing innovation
Transforming relationships Unleashing innovation Translating Discoveries Into Products A model for innovation driven economic growth Barbara Handelin, PhD 1 The Innovation Gap Economic Opportunity Industries
QLIKVIEW FOR LIFE SCIENCES. Partnering for Innovation and Sustainable Growth
QLIKVIEW FOR LIFE SCIENCES Partnering for Innovation and Sustainable Growth A BUSINESS MODEL BUILT FOR INSIGHT Success in today s life sciences industry requires insight into volumes of data, the sharing
BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover
The rocky way from science to market Dr. Karsten Fischer BioMedPartners AG VPM Days Hannover November 2013 Content I. Stage 1 II. Setbacks 6 III. Hope 12 IV. Solutions 17 V. Expertise 20 Page 1 The Challenge
MSD Information Technology Global Innovation Center. Digitization and Health Information Transparency
MSD Information Technology Global Innovation Center Digitization and Health Information Transparency 10 February 2014 1 We are seeking energetic, forward thinking graduates to join our Information Technology
Children's Hospital Boston - Strategic SWOT Analysis Review
Brochure More information from http://www.researchandmarkets.com/reports/1837823/ Description: Summary Children's Hospital Boston (Children s) is the pediatric medical center that provides a full range
The majority of pharmaceutical companies in
Pharmaceutical Infrastructure and Industry Professor Che-Ming Teng, Ph.D. National Taiwan University College of Medicine, Taipei, Taiwan The majority of pharmaceutical companies in Taiwan are devoted to
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences It s not information overload, it s filter failure. Clay Shirky Life Sciences organizations face the challenge
BOOSTING THE COMMERCIAL RETURNS FROM RESEARCH
BOOSTING THE COMMERCIAL RETURNS FROM RESEARCH Submission in response to the Discussion Paper November 2014 Page 1 ABOUT RESEARCH AUSTRALIA is an alliance of 160 members and supporters advocating for health
JOHN REID PhD, MBA. (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1
JOHN REID PhD, MBA (302) 544-1743 entrepidbd@gmail.com http://www.linkedin.com/in/jdreid1 PROFILE Senior-level business development and licensing executive with a well-honed ability to translate scientific
Domanda di innovazione nel mondo industriale. Modalità di interazione tra pubblico e privato
Domanda di innovazione nel mondo industriale. Modalità di interazione tra pubblico e privato Ennio Ongini Nicox Consiglio Nazionale delle Ricerche Quarta Giornata Informativa "Dalla ricerca al Trasferimento
Procurement must be more than just cost cutting
Procurement must be more than just cost cutting In today s challenging environment, aggressive cost control has become a common theme in the pharmaceutical industry. It became fashionable later than in
HUNT Biosciences AS Business plan 2010-2013
HUNT Biosciences AS Business plan 2010-2013 20 August 2009 Serious about biobanking 1 Table of contents Section Page 1. Executive Summary 3 2. Vision and Mission 4 3. Strategic Objectives 5 4. Organizational
Contents: Page 1-4 - Interviews with executive search consultants: * Luis Truchado, Founder and Partner, Eurogalenus, Madrid, Spain
This paper features one-on-one interviews with leading retained executive search consultants that are members of the Association of Executive Search Consultants (AESC), and specialize in placing senior
Drug Discovery in China
Drug Discovery in China Media Visit to Roche in China Shanghai 30 October 2005 Li Chen, Ph. D. Head of Research, Chief Scientific Officer Roche R&D Center (China) Ltd. Research Business Model in China
Profile of Biomedical Research and Biotechnology Commercialization. Philadelphia Wilmington Atlantic City Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization Philadelphia Wilmington Atlantic City Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Metropolitan